Evidence map›Paper›PMID 36505424›Full record

ArticleFrontiers in immunology2022

Chitosan particle stabilized Pickering emulsion/interleukin-12 adjuvant system for Pgp3 subunit vaccine elicits immune protection against genital chlamydial infection in mice.

Mingyi Shu, Lanhua Zhao, Keliang Shi, Wenbo Lei, Yewei Yang, Zhongyu Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mingyi ShuInstitute of Pathogenic Biology, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control- Hengyang Medical School, University of South China, Hengyang, China.
Lanhua ZhaoInstitute of Pathogenic Biology, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control- Hengyang Medical School, University of South China, Hengyang, China.
Keliang ShiInstitute of Pathogenic Biology, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control- Hengyang Medical School, University of South China, Hengyang, China.
Wenbo LeiInstitute of Pathogenic Biology, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control- Hengyang Medical School, University of South China, Hengyang, China.
Yewei YangInstitute of Pathogenic Biology, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control- Hengyang Medical School, University of South China, Hengyang, China.
Zhongyu LiInstitute of Pathogenic Biology, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control- Hengyang Medical School, University of South China, Hengyang, China.
University of South China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering the shortcomings in current chlamydia infection control strategies, a major challenge in curtailing infection is the implementation of an effective vaccine. The immune response induced by

Indexed as

ChitosanChlamydia InfectionsUrinary Tract InfectionsAdjuvants, ImmunologicAdjuvants, PharmaceuticAnimalsChlamydia trachomatisEmulsionsFemaleGenitaliaInterleukin-12MiceVaccines, SubunitAdjuvants, ImmunologicAdjuvants, PharmaceuticChitosanEmulsionsInterleukin-12Vaccines, Subunitchitosan particle stabilized Pickering emulsionchlamydia trachomatisimmune protectioninterleukin (IL)-12Pgp3 protein

Identifiers

PMID36505424
PMCPMC9727174
OpenAlexW4309707476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.